A novel pyrazoloacridone compound, KW-2170, in human cancer cell lines: The cellular sensitivity determinants and the synergistic combination.

被引：0
|
作者：
Sekikawa, T
Takano, H
Yamamoto, W
Nishiyama, M
机构：
[1] Hiroshima Univ, Res Inst Rad Biol Med, Dept Biochem Biophys, Hiroshima, Japan
[2] Showa Univ, Toyosu Hosp, Dept Internal Med, Tokyo, Japan
来源：
CLINICAL CANCER RESEARCH | 2000年 / 6卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
482
引用
收藏
页码：4563S / 4563S
页数：1
相关论文
共 47 条
  • [41] Antiproliferative activity of PEP005, a novel agent that activates PKCδ and inhibits PKCα, alone and in combination with cytotoxic agents in human solid tumor cancer cell lines.
    Benhadji, KA
    Serova, M
    Ghoul, A
    Cvitkovic, E
    Ogbourne, SM
    Welburn, P
    Faivre, S
    Lokiec, F
    Calvo, F
    Raymond, E
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9010S - 9011S
  • [42] Oleiferasaponin C6 from the seeds of Camellia oleifera Abel.: a novel compound inhibits proliferation through inducing cell-cycle arrest and apoptosis on human cancer cell lines in vitro
    Zong, Jianfa
    Wang, Dongxu
    Jiao, Weiting
    Zhang, Liang
    Bao, Guanhu
    Ho, Chi-Tang
    Hou, Ruyan
    Wan, Xiaochun
    RSC ADVANCES, 2016, 6 (94) : 91386 - 91393
  • [43] Determination of Pt-DNA adducts and the sub-cellular distribution of Pt in human cancer cell lines and the leukocytes of cancer patients, following mono- or combination treatments, by inductively-coupled plasma mass spectrometry
    Zayed, Aref
    Shoeib, Tamer
    Taylor, Sarah E.
    Jones, George D. D.
    Thomas, Anne L.
    Wood, Joanna P.
    Reid, Helen J.
    Sharp, Barry L.
    INTERNATIONAL JOURNAL OF MASS SPECTROMETRY, 2011, 307 (1-3) : 70 - 78
  • [44] Anti-cancer Effects of MW-03, a Novel Indole Compound, by Inducing 15-Hydroxyprostaglandin Dehydrogenase and Cellular Growth Inhibition in the LS174T Human Colon Cancer Cell Line
    Seira, Naofumi
    Yanagisawa, Naoki
    Suganami, Akiko
    Honda, Takuya
    Wasai, Makiko
    Regan, John W.
    Fukushimai, Keijo
    Yamaguchi, Naoto
    Tamura, Yutaka
    Arai, Takayoshi
    Murayama, Toshihiko
    Fujino, Hiromichi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (10) : 1806 - 1812
  • [45] Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity
    David-Beabes, GL
    Overman, MJ
    Petrofski, JA
    Campbell, PA
    De Marzo, AM
    Nelson, WG
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (06) : 1077 - 1086
  • [46] Rational combination of the IGF-1R/IR tyrosine kinase inhibitor (TKI), OSI-906, with the MEK inhibitor, U0126, results in synergistic and apoptotic effects in human colorectal cancer (CRC) cell lines
    Flanigan, Sara A.
    Pitts, Todd M.
    Kulikowski, Gillian N.
    Tan, Aik Choon
    Nallapareddy, Sujatha
    Tentler, John J.
    Eckhardt, S. Gail
    Leong, Stephen
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [47] Combination of the CDK4/6 inhibitor abemaciclib with xentuzumab, a humanized IGF-1 and IGF-2 ligand co-neutralizing monoclonal antibody, results in synergistic antineoplastic effects in human breast cancer cell lines
    Weyer-Czernilofsky, Ulrike
    Baumgartinger, Rosa
    Schmittner, Susanne
    Gong, Xueqian
    Buchanan, Sean
    Beckmann, Richard P.
    Marugan, Carlos
    Torres, Raquel
    Boehnke, Karsten
    Lallena, Maria Jose
    Solca, Flavio
    Kraut, Norbert
    Bogenrieder, Thomas
    CANCER RESEARCH, 2018, 78 (13)
12345